Moderna's on-chain trading volume surpasses $100 million, with open interest surging nearly threefold before rapidly declining.

BlockBeats news, October 23 - Moderna (MRNA) cancer vaccine clinical data was leaked ahead of schedule, triggering sharp fluctuations in its stock price, with MRNA perpetual contract trading on Hyperliquid surging in tandem.

According to TradingBeats monitoring, with the data outflow around 00:30 Beijing time today as the dividing line, MRNA contracts recorded cumulative trading volume of approximately 362,000 units in the following three hours, 9.1 times that of the previous three hours. The rolling 24-hour trading volume peaked at one point above $104 million; as of press time, the 24-hour trading volume is approximately $94.7 million, with the contract quoted at $203.33.

Before the news leaked, the notional open interest value of MRNA was approximately $6.84 million, rising to as high as $20.31 million around 2:00, an increase of about 197%, with the number of positions simultaneously surging from 30,500 units to 108,800 units.

This round of position expansion did not last. As of press time, MRNA notional OI has fallen back to approximately $6.27 million, with the number of positions dropping to 30,900 units, almost returning to pre-announcement levels.

In terms of whale trading, one account established a short position of 6,310.91 MRNA contracts during the decline, currently valued at approximately $1.283 million, making it the largest short position identified so far. Its average entry price was $188.304, but as the contract price rebounded from its low, the position is currently at a floating loss of approximately $95,000.